)
Edge29 May 2026
Who You Gonna Call? The Story of Rollins
How Rollins built one of America's most consistent businesses through recurring pest control, trusted local brands, and decades of acquisitions.
Respiratorius
Respiratorius (RESP) investor relations material
Respiratorius Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary26 May, 2026
Executive summary
Focused business development efforts in Q1 2026 led to positive market feedback, especially for the VAL001 candidate, with several pharmaceutical companies evaluating the project internally.
Participation at BIO Europe Spring 2026 resulted in valuable meetings and ongoing evaluations by potential partners.
No major external news communicated during the period, but patent protection for VAL001 was strengthened with new validations in SE, UK, and FR.
Current financing is assessed as sufficient to operate through February 2027.
Financial highlights
Net sales for Q1 2026 were 0 KSEK, unchanged from Q1 2025.
Result after financial items improved to -1,732 KSEK from -2,006 KSEK year-over-year.
Earnings per share were -0.22 SEK, compared to -0.39 SEK in Q1 2025.
Cash and bank balances at period end were 4,656 KSEK, down from 5,151 KSEK a year earlier.
Outlook and guidance
Management expects current funding to be adequate until February 2027, supporting ongoing business development and patent activities.
The company is optimistic about securing a partnership agreement for VAL001.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Respiratorius
- VAL001 advanced with regulatory, scientific, and financial milestones; strong equity and market outlook.RESP
Q4 202510 Feb 2026 - Regulatory progress and new funding position VAL001 for next steps, with losses narrowing.RESPQ3 202511 Nov 2025
- No revenue, continued losses, but major regulatory and commercial progress for VAL001.RESPQ2 202512 Aug 2025
- US patent win for VAL001 and strong liquidity position mark a pivotal Q3 for Respiratorius.RESPQ3 202413 Jun 2025
- Net loss narrowed and US patent for VAL001 granted, securing operations and future prospects.RESPQ2 202413 Jun 2025
- Losses narrowed, funding secured, and US patent granted for lead cancer drug VAL001.RESPQ4 20249 Jun 2025
- VAL001 shows strong promise for DLBCL, but losses persist amid zero revenue.RESPQ1 20256 Jun 2025
Next Respiratorius earnings date
Q2 202611 Aug, 2026
Respiratorius
Next Respiratorius earnings date
Q2 202611 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage